Immunome
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $4,015 | $2,926 |
Gross Profit | -776 | -49,193 | 3,295 | 2,926 |
EBITDA | -62,085 | -56,868 | -45,758 | -43,910 |
EBIT | -62,861 | -57,457 | -46,478 | -44,636 |
Net Income | -69,900 | -57,457 | -43,397 | -41,640 |
Net Change In Cash | 0 | 0 | 4,015 | 2,926 |
Free Cash Flow | -51,952 | -41,626 | -50,306 | -56,720 |
Cash | 653,482 | 272,639 | 143,876 | 257,613 |
Basic Shares | 87,350 | 87,957 | 87,010 | 79,410 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,941 | $9,041 | $14,018 | $6,627 |
Gross Profit | 3,986 | 9,041 | 14,018 | -631 |
EBITDA | -211,158 | -151,354 | -28,000 | -36,270 |
EBIT | -214,113 | -153,456 | -28,728 | -36,901 |
Net Income | -212,394 | -292,963 | -106,806 | -36,896 |
Net Change In Cash | 6,941 | 9,041 | 14,018 | 6,627 |
Cost of Revenue | -28,906 | |||
Free Cash Flow | -200,604 | -164,302 | -8,399 | -28,938 |
Cash | 653,482 | 143,351 | 98,679 | 20,323 |
Basic Shares | 87,350 | 58,639 | 19,843 | 12,126 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.76 |
2025-09-30 | -$0.65 |
2025-06-30 | -$0.50 |
